1 |
Hur, J.Y., Soh, Y., Kim, B.H., Suk, K., Sohn, N.W., Kim, H.C., Kwon, H.C., Lee, K.R. and Kim, S.Y. (2001). Neuroprotective and neurotrophic effects of quinic acids from Aster scaber in PC12 cells. Biol. Phwn. Bull. 24, 921-4
|
2 |
Jozaki, K., Marucha, P.T., Despins, A.W. and Kreutzer, D.L. (1990). An in vitro model of cell migration: Evaluation of vascular endothelial cell migration Anal. Biochem. 190, 39-47
|
3 |
Kahari, V.M. and Saarialho-Kcre, U. (1997). Matrix metalloprotemases in skin. Exp. Dermatol. 6, 199-213
|
4 |
Kim, C.M., Sin, M.K., An, T.K., Lee, K.S. and Lee, K.S. (ed.) (1997). 'Dictionary of Chinese Herb.' JungDam publisher, Seoul, p. 1431
|
5 |
Kim, M.S. Son, M. W., Kim, W. B., Park, Y. I., and Moon, A. (2000). Apicidin, an inhibitor of histone deacetylase, prevents H-ras-induced invasive phenotype. Cancer Lett. 157, 23-30
DOI
ScienceOn
|
6 |
Lee, T.-B. (1989). 'Illustrated Flora of Korea.' HyangMun. Publications, Seoul, p. 760
|
7 |
Stctler-Stevenson, W.G., Aznavoohan, S. and Liotta, L.A (1993). Tumor cell interactions with die extracellular matrix during invasion and metastasis. Annu. Rev. Cell Biol. 9, 541- 573
DOI
ScienceOn
|
8 |
Stetler-Stevenson, W.G. (1999). Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention. J. Clin. Invest. 103, 1237-1241
DOI
ScienceOn
|
9 |
Tryggvason, K., Hoyhtya, M., and Pyke, C. (1993). Type IV collagenase in invasive tumors. Breast Cancer Res. Treat. 24, 209-218
|
10 |
Ura, S.H., Bonfil, R.D., Reich, R., Reddel, R., Pfeifer, A., Hiris, C.C. and Klein-Szanto, A.J. (1989). Expression of type IV collagenase and procollagen genes and its correlation with the tumorigenic, invasive, and metastatic abilities of oncogenc-transformed human bronchial epithelial cells. Cancer Res. 49, 4615-4621
|
11 |
Liotta, L.A., Steeg, P-S. and Sletler-Stevenson, W.G. (1991). Canccr metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell. 64, 327-336
DOI
ScienceOn
|
12 |
Brown, P.D. (1999). Clinical studies with matrix metalloproteinases inhibitors. APMTS. 107, 174-180
|
13 |
Ferguson, L.R. (1994). Antimutagens as cancer chemopreventive agents in the diet. Mut. Res. 307, 395-410
DOI
ScienceOn
|
14 |
Gesa, M., Aathony, D.W. and Gabriele, M.K. (1999). Planta Medica. 65, 493-506
DOI
ScienceOn
|
15 |
Mahmood, N., Piacente, S., Burke, A., Khan, A. and Pizza, C. (1997). Antiviral Chemistry & Chemotherapy. 8, 70-74
DOI
|
16 |
Werb, Z., Vu, T.H., Rinkenberger, J.L. and Coussens, L.M. (1999). Matrix-degrading proteases and angiogenesis during development and tumor formation. APMIS. 107, 11-18
DOI
ScienceOn
|
17 |
Moon, A., Kim, M.S., Kim, T.G., Kim, S.H., Kim, H.E., Chen, Y.Q., and Kim, H. R. C. (2000). H-ras, but not N-ras, induces an invasive phenotype in human breast epithelial cells: A role for MMP-2 in the H-ras induced invasive phenotype. Int. J. Cancer. 85, 176-81
DOI
ScienceOn
|
18 |
Stavric B. (1994). Role of chemopreventers in human diet. Clinical Biochem. 27, 319-32
DOI
ScienceOn
|
19 |
Stetler-Stevenson, W.G. (1990). Type-IV collagenases in tumor invasion and metastasis. Cancer Metastasis Rev. 9, 289-303
DOI
ScienceOn
|
20 |
Yip, D., Ahmad, A., Karapetis, C.S., Hawkins, C.A. and Harper, P.G. (1999). Matrix metalloproteinase inhibitors: applications in oncology, Invest. New Dmgs. 17, 387-399
|